Cite
Sensitivity to CPT-11 and platinum derivatives of stage I/II node-negative breast, lung, and gastric cancer with occult neoplastic cells in lymph node sinuses.
MLA
Mukai, Masaya, et al. “Sensitivity to CPT-11 and Platinum Derivatives of Stage I/II Node-Negative Breast, Lung, and Gastric Cancer with Occult Neoplastic Cells in Lymph Node Sinuses.” Oncology Reports, vol. 18, no. 1, July 2007, pp. 33–39. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17549342&authtype=sso&custid=ns315887.
APA
Mukai, M., Sato, S., Ninomiya, H., Wakui, K., Komatsu, N., Matsui, N., Nakamura, M., Nakasaki, H., & Makuuchi, H. (2007). Sensitivity to CPT-11 and platinum derivatives of stage I/II node-negative breast, lung, and gastric cancer with occult neoplastic cells in lymph node sinuses. Oncology Reports, 18(1), 33–39.
Chicago
Mukai, Masaya, Shinkichi Sato, Hiromi Ninomiya, Kanako Wakui, Nobukazu Komatsu, Naruaki Matsui, Masato Nakamura, Hisao Nakasaki, and Hiroyasu Makuuchi. 2007. “Sensitivity to CPT-11 and Platinum Derivatives of Stage I/II Node-Negative Breast, Lung, and Gastric Cancer with Occult Neoplastic Cells in Lymph Node Sinuses.” Oncology Reports 18 (1): 33–39. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17549342&authtype=sso&custid=ns315887.